Student electives for Gina Hadley, Clare Webb, Zoeb Jiwaji, Emily Parker and Jonarthan Thevanayagam. (360G-Wellcome-083630_Z_07_Z)
Malaria is one of the deadliest infectious parasitic diseases. Combination therapy, which has already been introduced in Kenya may not address the problem of the ability of the parasite to quickly select for resistance against antimalarial drugs, due to the detrimental effect of disparate pharmacokinetic profiles of drugs used. Strategies have to be devised to tackle the drug resistance. One such strategy is to predict and monitor the emergence and the spread of drug resistance parasite before drug resistance become s a problem. As Co-artem® has already been introduced in Kenya, the information that this project will provide is vital.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Region | South East |
| Award Date | 2007-02-28T00:00:00+00:00 |
| Internal ID | 083630/Z/07/Z |
| Planned Dates: End Date | 2008-08-10T00:00:00+00:00 |
| Planned Dates: Start Date | 2007-07-11T00:00:00+00:00 |
| Amount Awarded | 5600 |
| Financial Year | 2006/07 |
| Lead Applicant | Dr Tim Lancaster |
| Grant Programme: Title | Student Elective |
| Applicant Surname | Lancaster |
| Approval Committee | Neurosciences And Mental Health |
| Recipient Org: Country | United Kingdom |
| Recipient Org: City | Oxford |
| Has the grant transferred? | No |
| Research conducted at multiple locations? | No |
| Total amount including partnership funding | 5600 |